During the past decade, Bayer HealthCare LLC, Diabetes Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bayer HealthCare LLC, Diabetes Care" are "Diabetes" (7 trials). Many other conditions were trialed in "Bayer HealthCare LLC, Diabetes Care" in a lesser frequency.

Most popular intervention types in "Bayer HealthCare LLC, Diabetes Care" are "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "ACCU-CHEK® Aviva BGMS" (1 trials), "Accu-Chek® Active BGMS" (1 trials), "Accu-Chek® Performa BGMS" (1 trials), "Apollo Evolution Investigational BG Monitoring System" (1 trials) and "CONTOUR® NEXT EZ BGMS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bayer HealthCare LLC, Diabetes Care" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Bayer HealthCare LLC, Diabetes Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Bayer HealthCare LLC, Diabetes Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bayer HealthCare LLC, Diabetes Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".